Silvio E Inzucchi Selected Research

Hypoglycemic Agents (Hypoglycemics)

1/2022	DCRM Multispecialty Practice Recommendations for the management of diabetes, cardiorenal, and metabolic diseases.
1/2019	Treating Heart Failure With Antihyperglycemic Medications: Is Now the Right Time?
1/2018	Hypoglycemia in type 2 diabetes: understanding patients' and physicians' knowledge and experience.
6/2017	Pioglitazone and cardiovascular risk reduction: time for a second look?
9/2014	Using the glucometrics website to benchmark ICU glucose control before and after the NICE-SUGAR study.
6/2014	Rationale, design, and baseline characteristics of a randomized, placebo-controlled cardiovascular outcome trial of empagliflozin (EMPA-REG OUTCOME™).
3/2013	Computerization of the Yale insulin infusion protocol and potential insights into causes of hypoglycemia with intravenous insulin.
3/2013	The efficacy and safety of imeglimin as add-on therapy in patients with type 2 diabetes inadequately controlled with metformin monotherapy.
9/2012	Discontinuation of antihyperglycemic therapy after acute myocardial infarction: medical necessity or medical error?
5/2010	Discontinuation of antihyperglycemic therapy and clinical outcomes after acute myocardial infarction in older patients with diabetes.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Silvio E Inzucchi Research Topics

Disease

108	Type 2 Diabetes Mellitus (MODY) 11/2022 - 01/2002
90	Heart Failure 11/2022 - 07/2003
32	Myocardial Infarction 01/2022 - 06/2005
29	Cardiovascular Diseases (Cardiovascular Disease) 11/2022 - 07/2005
29	Stroke (Strokes) 01/2022 - 06/2003
25	Insulin Resistance 01/2022 - 03/2002
21	Hypoglycemia (Reactive Hypoglycemia) 01/2022 - 12/2004
20	Hyperglycemia 08/2016 - 06/2004
14	Diabetes Mellitus 03/2022 - 06/2004
14	Transient Ischemic Attack 01/2019 - 06/2003
14	Ischemic Stroke 12/2018 - 06/2003
13	Critical Illness (Critically Ill) 01/2016 - 02/2004
11	Albuminuria 01/2021 - 03/2015
10	Chronic Renal Insufficiency 11/2022 - 12/2014
10	Kidney Diseases (Kidney Disease) 11/2022 - 12/2014
6	Prediabetic State (Prediabetes) 01/2022 - 01/2003
6	Bone Fractures (Bone Fracture) 01/2022 - 04/2016
5	Cardiomyopathies (Cardiomyopathy) 09/2022 - 10/2019
5	Atrial Fibrillation 01/2022 - 01/2018
5	Infections 01/2021 - 11/2015
5	Weight Loss (Weight Reduction) 01/2020 - 01/2018
5	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2018 - 01/2005
4	Neoplasms (Cancer) 01/2021 - 09/2004
4	Body Weight (Weight, Body) 01/2021 - 07/2010
4	Obesity 01/2019 - 01/2003
4	Overweight 01/2019 - 01/2018
4	Coronary Artery Disease (Coronary Atherosclerosis) 01/2018 - 01/2015
4	Glucose Intolerance 01/2011 - 01/2003
3	Obstructive Sleep Apnea 05/2022 - 12/2020
3	Weight Gain 01/2022 - 04/2016
3	Hypertension (High Blood Pressure) 01/2022 - 01/2018
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021 - 01/2011
3	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 01/2021 - 08/2016
3	Diabetic Nephropathies (Diabetic Nephropathy) 12/2020 - 01/2018
3	Lactic Acidosis 10/2020 - 12/2014
3	Atherosclerosis 01/2019 - 07/2005
3	Acute Coronary Syndrome 01/2019 - 11/2008
3	Ischemia 04/2009 - 08/2004
2	Chronic Obstructive Pulmonary Disease (COPD) 04/2022 - 01/2021
2	Non-alcoholic Fatty Liver Disease 01/2022 - 01/2022
2	Heart Diseases (Heart Disease) 01/2022 - 01/2021
2	Proteinuria 01/2022 - 01/2015
2	Gout 01/2022 - 01/2022
2	Stable Angina 12/2020 - 10/2015
2	Hypovolemia 10/2020 - 08/2016
2	Coronary Disease (Coronary Heart Disease) 01/2019 - 10/2015
2	Vascular Diseases (Vascular Disease) 01/2019 - 01/2005
2	Unstable Angina 01/2018 - 05/2017
2	Edema (Dropsy) 01/2018 - 04/2016
2	Pituitary Neoplasms (Pituitary Adenoma) 01/2018 - 07/2014

Drug/Important Bio-Agent (IBA)

74	Glucose (Dextrose)FDA LinkGeneric 11/2022 - 01/2003
59	empagliflozinIBA 05/2022 - 06/2014
38	dapagliflozinIBA 09/2022 - 01/2019
36	Insulin (Novolin)FDA Link 04/2022 - 03/2002
23	Pioglitazone (Actos)FDA Link 01/2022 - 06/2003
22	Metformin (Glucophage)FDA LinkGeneric 01/2021 - 01/2003
18	Hypoglycemic Agents (Hypoglycemics)IBA 01/2022 - 01/2002
17	Blood Glucose (Blood Sugar)IBA 11/2022 - 06/2003
17	SodiumIBA 11/2022 - 01/2017
17	Sodium-Glucose Transporter 2 InhibitorsIBA 11/2022 - 06/2014
15	Sodium-Glucose Transport ProteinsIBA 01/2022 - 11/2015
15	Pharmaceutical PreparationsIBA 01/2022 - 01/2002
9	DiureticsIBA 01/2022 - 08/2016
8	CreatinineIBA 12/2020 - 07/2016
6	omega-Chloroacetophenone (Mace)IBA 01/2020 - 01/2018
6	ThiazolidinedionesIBA 01/2019 - 03/2002
5	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2022 - 10/2019
5	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2021 - 05/2012
5	AlbuminsIBA 12/2020 - 01/2017
4	pro-brain natriuretic peptide (1-76)IBA 09/2022 - 10/2019
4	Natriuretic PeptidesIBA 09/2022 - 10/2019
4	Uric Acid (Urate)IBA 01/2022 - 03/2015
4	SymportersIBA 10/2021 - 01/2019
4	2,4-thiazolidinedione (thiazolidinedione)IBA 01/2019 - 07/2003
4	lorcaserinIBA 01/2019 - 01/2018
4	5-HT2C Serotonin ReceptorIBA 01/2019 - 01/2018
4	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2019 - 01/2015
4	Adenosine (Adenocard)FDA LinkGeneric 09/2013 - 08/2004
3	Triglycerides (Triacylglycerol)IBA 01/2021 - 03/2002
3	Liraglutide FDA Link 01/2019 - 09/2017
3	Hemoglobins (Hemoglobin)IBA 01/2019 - 12/2010
3	CanagliflozinIBA 01/2019 - 01/2018
3	Angiotensin Receptor AntagonistsIBA 01/2019 - 08/2017
2	LipidsIBA 01/2022 - 03/2002
2	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2022 - 02/2021
2	HDL CholesterolIBA 01/2021 - 11/2020
2	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 01/2021 - 01/2020
2	Rosiglitazone (Avandia)FDA Link 01/2019 - 03/2002
2	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 07/2018 - 07/2014
2	C-Reactive ProteinIBA 01/2018 - 08/2004
2	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2018 - 07/2014
2	SugarsIBA 09/2014 - 03/2013
2	imegliminIBA 07/2014 - 03/2013

Therapy/Procedure

65	Therapeutics 11/2022 - 01/2002
22	Glycemic Control 04/2021 - 01/2002
9	Secondary Prevention 01/2022 - 12/2014
3	Patient Readmission 12/2019 - 07/2005
2	Surgical Amputation (Amputations) 10/2018 - 01/2018
2	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2018 - 07/2016
2	Length of Stay 01/2018 - 04/2011